share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

Hong Kong Stock Exchange ·  Apr 23 05:12
Summary by Moomoo AI
無錫藥明康德於2024年3月8日至4月23日期間，透過上海證券交易所回購股份。根據香港聯合交易所有限公司證券上市規則，公司需披露股份變動情況。在此期間，藥明康德共回購了多批A股股份，每次回購股份數目及百分比均有所不同，回購價格亦隨市場價格波動。該公司於4月23日的回購為最新一次，當日回購了475,700股A股，每股價格介乎RMB 41.49至RMB 43.17，總付出金額為RMB 20,047,986.38。此系列股份回購行動顯示藥明康德對公司股價的信心，並可能對市場信心和股價產生積極影響。
無錫藥明康德於2024年3月8日至4月23日期間，透過上海證券交易所回購股份。根據香港聯合交易所有限公司證券上市規則，公司需披露股份變動情況。在此期間，藥明康德共回購了多批A股股份，每次回購股份數目及百分比均有所不同，回購價格亦隨市場價格波動。該公司於4月23日的回購為最新一次，當日回購了475,700股A股，每股價格介乎RMB 41.49至RMB 43.17，總付出金額為RMB 20,047,986.38。此系列股份回購行動顯示藥明康德對公司股價的信心，並可能對市場信心和股價產生積極影響。
Wuxi Yuma Ming Kand repurchased shares through the Shanghai Stock Exchange from 8 March to 23 April 2024. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in shares. During this period, Pharmaceutical Co., Ltd has repurchased multiple A shares. The number and percentage of shares each repurchase vary, and the repurchase price also fluctuates with market prices. The Company's most recent repurchase on April 23 saw 475,700 shares of A shares repurchased on the same day at prices ranging from RMB 41.49 to RMB 43.17 for a total payout of RMB 20,047,986.38. This series of share repurchases demonstrates the confidence that Pharmaceutical Company has in its share price and may have a positive impact on market confidence and share price.
Wuxi Yuma Ming Kand repurchased shares through the Shanghai Stock Exchange from 8 March to 23 April 2024. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in shares. During this period, Pharmaceutical Co., Ltd has repurchased multiple A shares. The number and percentage of shares each repurchase vary, and the repurchase price also fluctuates with market prices. The Company's most recent repurchase on April 23 saw 475,700 shares of A shares repurchased on the same day at prices ranging from RMB 41.49 to RMB 43.17 for a total payout of RMB 20,047,986.38. This series of share repurchases demonstrates the confidence that Pharmaceutical Company has in its share price and may have a positive impact on market confidence and share price.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more